Indications & Uses
Deca-Durabolin is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Established Osteoporosis: 50 mg every 3 weeksDisseminated breast cancer in women (palliative therapy): 50 mg every 3 weeksProtein deficiency states occurring after major surgery or trauma: 50 mg every 2-3 weeksAnemia due to chronic renal failure: 50-200 mg per weekAplastic anemia: 50-150 mg per weekAnemia due to cytotoxic therapy: 200 mg per weekChronic debilitating disease in elderly: 100 mgPostsurgical and post-traumatic catabolism: 25-50 mg every 3 weeksDuring glucocorticosteroid therapy: 50 mg every 2-3 weekShould be administered by deep intramuscular injection. For an optimal therapeutic effect it is necessary to administer adequate amounts of vitamins, minerals and protein in a calorie-rich diet.
Side Effects
Due to the nature of the drug, side effects cannot be quickly reversed by discontinuing medication. Injectables in general, may cause a local reaction at the injection site. Depending on the dose, frequency and total period of administration of Decabolon the following undesirable effects may occur: Virilism, Hyperlipidaemia, Increased Libido, Hypertension, Dysphonia, Nausea, Abnormal hepatic function, Peliosis hepatis, Acne, Rash, Pruritus, Hirsutism, Premature fusion of Epiphyses, Decreased urine flow, Benign prostatic hyperplasia, Priapism, Enlarged penis, clitoris, Amenorrhoea, Oligomenorrhoea, Decreased sperm count, Oedema, Injection site reaction, Decreased HDL, increased Haemoglobin.
Cautions & Contraindications
Warnings & Precautions
If signs of virilisation develop, discontinuation of the treatment should be considered, preferably in consultation with the patient.It is recommended to monitor patients with any of the following conditions: latent or overt cardiac failure, renal dysfunction, hypertension of migraine (or a history of these conditions), since anabolic steroids may occasionally induce fluid retention incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure skeletal metastases of breast carcinoma. In these patients hypercalcaemia may develop both spontaneously and as a result of anabolic steroid therapy. The later can be indicative of a positive tumour response to the hormonal treatment. Nevertheless, the hypercalcaemia should first be treated appropriately and after restoration of normal calcium levels hormone therapy can be resumed liver dysfunction The use of anabolic steroids to enhance athletic ability may carry severe risks to the user's health and should be discouraged
Contraindications
Contraindicated in Pregnancy, Male breast carcinoma, Prostatic carcinoma, The patients allergic to peanuts & soya and hypersensitive to the active substance or to any of the excipients including arachis oil.